Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/18/2003US6649364 Anti-apoptotic compositions and methods using same
11/18/2003US6649353 Method for influencing the p53 linkage to target genes
11/18/2003US6649349 Peptide nucleic acid for use in the diagnosis, detection and prevention of blood, respiratory and cancer disorders
11/18/2003US6649346 Methods of identifying agents that affect cleavage of amyloid-β precursor protein
11/18/2003US6649342 Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
11/18/2003US6649341 Detection of cancerous lymphocytes by isolating mRNA, hybridizing a probe specific for given nucleotide sequence and determining presence of transcript product; use in diagnosis/treatment of leukemia; hormone therapy
11/18/2003US6649340 Protein which contains a predetermined amino acid in the hypervariable region of the antigen-binding site; use in studying structure/ function and in developing new enzymes and antibodies
11/18/2003US6649171 Diagnostic, prophylactic and therapeutic uses, i.e. vaccines; antibiotic resistant bacteria responsible for much of the otitis media in young children
11/18/2003US6649169 Cold-adapted equine influenza viruses
11/18/2003US6649167 Papillomavirus truncated L1 protein and fusion protein constructs
11/18/2003US6649164 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/18/2003US6649158 Methods and compositions to induce antitumor response
11/18/2003US6649143 Non-invasive localization of a light-emitting conjugate in a mammal
11/18/2003CA2265508C Bone morphogenetic protein-16 (bmp-16) compositions
11/18/2003CA2223433C Ob protein compositions and methods
11/18/2003CA2143845C Self-assembling recombinant papillomavirus capsid proteins
11/18/2003CA2045208C Inhibition of coloration of human serum albumin
11/18/2003CA1341447C Mutant t-pa with kringle replacement
11/17/2003CA2429483A1 Immunointeractive molecules
11/17/2003CA2387006A1 A novel mouse with deficiency of gene of neutrophil chemotactic factor lect2
11/13/2003WO2003094088A1 Mouse olfactory receptor gene superfamily specification
11/13/2003WO2003093817A2 Method of identifying ligands for nuclear receptors
11/13/2003WO2003093787A2 Antiproliferative protein from hypericum perforatum and nucleic acids encoding the same
11/13/2003WO2003093510A1 Compositions and methods relating to colon specific genes and proteins
11/13/2003WO2003093492A2 Compositions and methods for determining susceptibility of hepatitis c virus to anti-viral drugs
11/13/2003WO2003093485A2 Optimization of transgene expression in mammalian cells
11/13/2003WO2003093484A1 Insect resistant plants and methods for making the same
11/13/2003WO2003093481A1 Nucleic acid for autonomous replication in micro-organisms of the acetobacteraceae family
11/13/2003WO2003093480A2 Immortalized hypothalamic neuronal cell lines
11/13/2003WO2003093476A1 Vector with modified protease-dependent tropism
11/13/2003WO2003093475A1 Compositions and methods for the modification of gene expression_using the superubiquitin promoter from pinus radiata
11/13/2003WO2003093474A1 Psp94 binding protein and psp94 diagnostic assays
11/13/2003WO2003093470A1 Gene relating to saccharide metabolism or lipid metabolism
11/13/2003WO2003093468A2 Expression system for large functional proteins
11/13/2003WO2003093465A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS
11/13/2003WO2003093463A1 Improved viral purification methods
11/13/2003WO2003093461A2 Genomic library of cyanophage s-2l and functional analysis
11/13/2003WO2003093455A2 Adenovirus vectors for immunotherapy
11/13/2003WO2003093453A2 Bacillus licheniformis mutant host cell
11/13/2003WO2003093452A2 Variants of nedd4l associated with hypertension and viral budding
11/13/2003WO2003093451A2 Transposable elements in rice and methods of use
11/13/2003WO2003093450A2 Maize clavata3-like polynucleotide sequences and methods of use
11/13/2003WO2003093444A2 Transporters and ion channels
11/13/2003WO2003093443A2 Alcam and alcam modulators
11/13/2003WO2003093439A2 Enzymes
11/13/2003WO2003093437A2 Production of papillomavirus vaccines in plants
11/13/2003WO2003093434A2 Nanoarchaeum nucleic acid molecule
11/13/2003WO2003093432A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003WO2003093431A2 Ablated slam-dependent entry
11/13/2003WO2003093423A2 Mta1s, a steroid hormone receptor corepressor
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093418A2 Keratinocytes expressing exogenous angiogenic growth factors
11/13/2003WO2003093416A2 Protective antigens for the control of ixodes species infestations
11/13/2003WO2003093415A2 Methods useful in treatment and prevention of hiv infection
11/13/2003WO2003093413A2 Barnacle adhesion proteins
11/13/2003WO2003093411A2 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/13/2003WO2003093409A2 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003WO2003093321A1 Fusion polypeptide, use thereof and methods employing it
11/13/2003WO2003093316A2 Immunoglobulin-domain containing cell surface recognition molecules
11/13/2003WO2003093315A2 Specific antibody fragments for the human carcinoembryonic antigen (cea)
11/13/2003WO2003093314A2 Connective tissue stimulating peptides
11/13/2003WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003WO2003093312A1 Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha)
11/13/2003WO2003093310A1 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland
11/13/2003WO2003093309A1 Crystal structure of acetyl choline binding protein
11/13/2003WO2003093308A1 Metallo proteinase inhibitory agent
11/13/2003WO2003093307A2 Mycobacterial antigens and uses thereof
11/13/2003WO2003093306A2 Nucleic acids and proteins from streptococcus groups a & b
11/13/2003WO2003093305A2 Teneurin c-terminal associated peptides (tcap) and uses thereof
11/13/2003WO2003093303A1 Targeting proteins to deliver therapeutic or diagnostic reagents
11/13/2003WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
11/13/2003WO2003093299A2 Insulin-associated peptides with effects on cerebral health
11/13/2003WO2003093298A2 Immunogenic peptides
11/13/2003WO2003093296A2 Kinase anchor protein muteins, peptides thereof, and related methods
11/13/2003WO2003093294A2 Conformationally constrained peptides that bind the orl-1 receptor
11/13/2003WO2003093293A2 Peptide antagonists of tgf-beta family members and therapeutic uses thereof
11/13/2003WO2003092869A1 Method for chemical analysis of biological materials
11/13/2003WO2003092737A1 Fusions of cytokines and tumor targeting proteins
11/13/2003WO2003092735A2 Peptide nucleic acid conjugates with beta-amino acid polymers or reptoids
11/13/2003WO2003092724A1 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/13/2003WO2003092723A1 Use of fasl for the treatment of neurodegenerative diseases
11/13/2003WO2003092717A1 Cancer immunotherapy
11/13/2003WO2003092708A1 Antitumor agents with the use of hsv
11/13/2003WO2003092611A2 Methods of inducing formation of functional and organized lymphatic vessels
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003092593A2 Tumor suppressor gene polypeptides
11/13/2003WO2003092587A2 Modulation of bacterial membrane permeability
11/13/2003WO2003092582A2 Chimeric ebola virus envelopes and uses therefor
11/13/2003WO2003092370A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
11/13/2003WO2003080654A3 Helicobacter flagellar, motility polypeptides
11/13/2003WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof
11/13/2003WO2003068804A3 Novel insect cell line
11/13/2003WO2003066820A3 Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof
11/13/2003WO2003066680A3 Antigens for immunocontraception
11/13/2003WO2003064587A3 Hif-1 alpha proteins mutated in the c-terminal transactivation domain
11/13/2003WO2003061680A3 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003047526A3 Cell adhesion and extracellular matrix proteins
1 ... 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 ... 2916